Karin Nachbaur

1.4k total citations
17 papers, 1.1k citations indexed

About

Karin Nachbaur is a scholar working on Surgery, Hepatology and Epidemiology. According to data from OpenAlex, Karin Nachbaur has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Hepatology and 7 papers in Epidemiology. Recurrent topics in Karin Nachbaur's work include Organ Transplantation Techniques and Outcomes (8 papers), Liver Disease Diagnosis and Treatment (7 papers) and Liver Disease and Transplantation (5 papers). Karin Nachbaur is often cited by papers focused on Organ Transplantation Techniques and Outcomes (8 papers), Liver Disease Diagnosis and Treatment (7 papers) and Liver Disease and Transplantation (5 papers). Karin Nachbaur collaborates with scholars based in Austria, United Kingdom and Germany. Karin Nachbaur's co-authors include Ivo Graziadei, Raimund Margreiter, Wolfgang Vogel, Alfred Koenigsrainer, Werner Jaschke, W. Vogel, Peter Waldenberger, Armin Finkenstedt, Robert Koch and H Schwaighofer and has published in prestigious journals such as Hepatology, Journal of Hepatology and American Journal of Transplantation.

In The Last Decade

Karin Nachbaur

17 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karin Nachbaur Austria 14 782 538 484 157 115 17 1.1k
Suk‐Won Suh South Korea 18 613 0.8× 584 1.1× 290 0.6× 132 0.8× 50 0.4× 71 979
Ana Paula Barreiros Germany 16 307 0.4× 319 0.6× 306 0.6× 69 0.4× 63 0.5× 28 721
Chee‐Chien Yong Taiwan 17 747 1.0× 673 1.3× 309 0.6× 124 0.8× 29 0.3× 103 977
Rafael Soares Pinheiro Brazil 15 430 0.5× 415 0.8× 195 0.4× 93 0.6× 90 0.8× 76 766
Sandra J. Beaver United States 13 1.1k 1.4× 689 1.3× 695 1.4× 499 3.2× 71 0.6× 15 1.4k
Geun Hong South Korea 15 580 0.7× 466 0.9× 314 0.6× 101 0.6× 60 0.5× 48 786
Koichi Urata Japan 15 1.1k 1.4× 1.1k 2.1× 376 0.8× 78 0.5× 73 0.6× 33 1.3k
Shoji Hiroshige Japan 17 685 0.9× 799 1.5× 227 0.5× 78 0.5× 42 0.4× 31 957
Franklin Greif Israel 13 313 0.4× 575 1.1× 74 0.2× 272 1.7× 54 0.5× 39 802
Benno Cardini Austria 16 260 0.3× 498 0.9× 110 0.2× 105 0.7× 139 1.2× 61 724

Countries citing papers authored by Karin Nachbaur

Since Specialization
Citations

This map shows the geographic impact of Karin Nachbaur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Nachbaur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Nachbaur more than expected).

Fields of papers citing papers by Karin Nachbaur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Nachbaur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Nachbaur. The network helps show where Karin Nachbaur may publish in the future.

Co-authorship network of co-authors of Karin Nachbaur

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Nachbaur. A scholar is included among the top collaborators of Karin Nachbaur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Nachbaur. Karin Nachbaur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Viveiros, André, Benedikt Schaefer, Armin Finkenstedt, et al.. (2020). Reduced iron export associated with hepcidin resistance can explain the iron overload spectrum in ferroportin disease. Liver International. 40(8). 1941–1951. 13 indexed citations
2.
Finkenstedt, Armin, Karin Nachbaur, Heinz Zoller, et al.. (2013). Acute-on-chronic liver failure: Excellent outcomes after liver transplantation but high mortality on the wait list. Liver Transplantation. 19(8). 879–886. 130 indexed citations
3.
Graziadei, Ivo, Heinz Zoller, Karin Nachbaur, et al.. (2012). Early viral load and recipient interleukin-28B rs12979860 genotype are predictors of the progression of hepatitis C after liver transplantation. Liver Transplantation. 18(6). 671–679. 24 indexed citations
4.
Finkenstedt, Armin, Ivo Graziadei, Karin Nachbaur, et al.. (2009). Transjugular intrahepatic portosystemic shunt in liver transplant recipients. World Journal of Gastroenterology. 15(16). 1999–1999. 13 indexed citations
5.
Finkenstedt, Armin, Ivo Graziadei, Wilhelm Oberaigner, et al.. (2009). Extensive Surveillance Promotes Early Diagnosis and Improved Survival of De Novo Malignancies in Liver Transplant Recipients. American Journal of Transplantation. 9(10). 2355–2361. 101 indexed citations
6.
Graziadei, Ivo, H Schwaighofer, Robert Koch, et al.. (2006). Long-term outcome of endoscopic treatment of biliary strictures after liver transplantation. Liver Transplantation. 12(5). 718–725. 153 indexed citations
7.
Graziadei, Ivo, Karin Nachbaur, Wolfgang Vogel, et al.. (2005). Fatal course of parvovirus B19-associated myocarditis in a female liver transplant recipient. Liver Transplantation. 11(4). 463–466. 14 indexed citations
8.
Koch, Robert, et al.. (2004). Long-term efficacy and safety of mycophenolate mofetil in liver transplant recipients with calcineurin inhibitor-induced renal dysfunction. Transplant International. 17(9). 518–524. 40 indexed citations
9.
Koch, Robert, Ivo Graziadei, Karin Nachbaur, et al.. (2004). Long-term efficacy and safety of mycophenolate mofetil in liver transplant recipients with calcineurin inhibitor-induced renal dysfunction. Transplant International. 17(9). 518–524. 39 indexed citations
10.
Graziadei, Ivo, Peter Waldenberger, Alfred Koenigsrainer, et al.. (2003). Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transplantation. 9(6). 557–563. 341 indexed citations
11.
Steindl‐Munda, Petra, Peter Ferenci, H. Brünner, et al.. (2003). Impact of high‐dose interferon induction and ribavirin therapy in patients with chronic hepatitis C relapsing after or not responding to interferon monotherapy. Liver International. 23(4). 269–275. 11 indexed citations
12.
Ferenci, Peter, H. Brünner, Karin Nachbaur, et al.. (2001). Combination of interferon induction therapy and ribavirin in chronic hepatitis C. Hepatology. 34(5). 1006–1011. 102 indexed citations
13.
Kaser, Susanne, Bernhard Föger, Peter Waldenberger, et al.. (2000). Transjugular intrahepatic portosystemic shunt (TIPS) augments hyperinsulinemia in patients with cirrhosis. Journal of Hepatology. 33(6). 902–906. 17 indexed citations
14.
Propst, Theresa, A Propst, Karin Nachbaur, et al.. (1997). Papillitis and vasculitis of the arteria spinalis anterior as complications of hepatitis C reinfection after liver transplantation. Transplant International. 10(3). 234–237. 19 indexed citations
17.
Gastl, Günther, Walter E. Aulitzky, Herbert Tilg, et al.. (1986). A Biological Approach to Optimize Interferon Treatment in Hairy Cell Leukemia. Immunobiology. 172(3-5). 262–268. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026